Phacoemulsification Cataract Extraction in Patient with Behçet's Disease
AbstractThe safety and the efficacy of phacoemulsification cataract surgery in Behçet's disease are evaluated in this report. Retrospective study of phacoemulsification cataract surgeries performed in patients with Behçet's disease in our hospital. All patients were free of inflammation for 3 months prior to surgery. Patients were followed up by visual acuity and for signs of ocular relapses of Behçet's disease for at least 4 months. Thirteen eyes of 8 patients with Behçet's disease were enrolled in the study. There were seven males and one female patient; both eyes were included in 5 male patients. The mean age at time of presentation was 29.5 (range 25-42) years. The mean pre-operative best corrected visual acuity was 0.94 (range 0.48 to 2.0). The mean postoperative visual acuity was 0.35 (range 0.1 to 1.3) (p = 0.0002). One patient had posterior capsular opacification, while another patient developed subretinal choroidal neovascular membrane. Two (15.3%) patients had transient rise of the intraocular pressure. Cataract surgery with phacoemulsification is safe and effective in the patients with Behçet's disease, provided they were well managed before, during and after the surgery.
Copyright (c) 2010 Journal of King Abdulaziz University - Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.